MC
Moelis & Co Financials Investment Advice Russell 3000
$58.59Close
$50.37 – $75.4752-week range
Nov 5, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 2 of 8 trend conditions
- Lagging the market RS 24 · weaker than 76% of stocks over 12 months
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
22%
1wk
up 7.4%
price change
1mo
up 1.9%
price change
12-month return
down 5%
market up 11% ·
its own down 20%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
—
year on year
EPS growth
—
latest quarter
Sales growth
—
latest quarter
ROE
up 51%
return on equity
Free cash margin
—
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Trade setup
ATR%
3.6%
$2.11 a day · 2×ATR $54.37
RS
24 / 99
vs the universe
Trend
2 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
0.73
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 2 of 8
- 150-day average above the 200-day: passes
- Within 25% of the 52-week high: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- No material dilution
- Margins and revenue not shrinking
Last reported
Jul 29, 2026
Financials
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Operating income | $265.7M | $495.9M | $216.1M | -$40.4M | $172.9M | $273.9M |
| Net income | $218.4M | $423.0M | $168.7M | -$27.5M | $151.5M | $259.6M |
| Cash | $202.5M | $520.2M | $206.8M | $186.4M | $412.5M | $508.6M |
| Shareholders' equity | $479.9M | $489.1M | $444.5M | $352.1M | $441.6M | $568.4M |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Jul 30, 2026 | Quarterly ↗ | Jun 30, 2026 | 30d |
| Apr 30, 2026 | Quarterly ↗ | Mar 31, 2026 | 30d |
| Feb 26, 2026 | Annual ↗ | Dec 31, 2025 | 57d |
| Oct 30, 2025 | Quarterly ↗ | Sep 30, 2025 | 30d |
| Jul 25, 2025 | Quarterly ↗ | Jun 30, 2025 | 25d |
| Apr 24, 2025 | Quarterly ↗ | Mar 31, 2025 | 24d |
| Feb 27, 2025 | Annual ↗ | Dec 31, 2024 | 58d |
| Oct 24, 2024 | Quarterly ↗ | Sep 30, 2024 | 24d |
| Jul 25, 2024 | Quarterly ↗ | Jun 30, 2024 | 25d |
| Apr 25, 2024 | Quarterly ↗ | Mar 31, 2024 | 25d |
| Feb 22, 2024 | Annual ↗ | Dec 31, 2023 | 53d |
| Nov 3, 2023 | Quarterly ↗ | Sep 30, 2023 | 34d |
Current reports
| Filed | Disclosed |
|---|---|
| Jul 29, 2026 | Results · Regulation FD ↗ |
| Jun 26, 2026 | Shareholder vote ↗ |
| Apr 29, 2026 | Results · Regulation FD ↗ |
| Feb 4, 2026 | Results · Regulation FD ↗ |
| Oct 29, 2025 | Results · Regulation FD ↗ |
| Jul 24, 2025 | Results · Regulation FD ↗ |
| Jul 1, 2025 | Director or officer change · Regulation FD ↗ |
| Jun 9, 2025 | Director or officer change · Regulation FD ↗ |
| Jun 6, 2025 | Shareholder vote ↗ |
| Apr 23, 2025 | Results · Regulation FD ↗ |
| Feb 27, 2025 | Director or officer change · Regulation FD ↗ |
| Feb 10, 2025 | Director or officer change ↗ |